Bendamustine EG 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Bendamustine Hydrochloride 25 mg

Available from:

EG SA-NV

ATC code:

L01AA09

INN (International Name):

Bendamustine Hydrochloride

Dosage:

2,5 mg/ml

Pharmaceutical form:

Powder for concentrate for solution for infusion

Composition:

Bendamustine Hydrochloride 25 mg

Administration route:

Intravenous use

Therapeutic area:

Bendamustine

Product summary:

CTI code: 485404-04 - Pack size: 20 x 25 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 485404-03 - Pack size: 10 x 25 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 485404-02 - Pack size: 5 x 25 mg - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 485404-01 - Pack size: 25 mg - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2016-01-11